本页面由Tiger Trade Technology Pte. Ltd.提供服务

Aeglea BioTherapeutics, Inc.

12.01
0.0000
成交量:- -
成交额:50.26万
市值:4,862.76万
市盈率:-0.16
高:12.01
开:12.01
低:12.01
收:12.01
52周最高:39.00
52周最低:2.66
股本:404.89万
流通股本:192.19万
量比:- -
换手率:- -
股息:- -
股息率:- -
每股收益(TTM):-75.0117
每股收益(LYR):-24.8618
净资产收益率:-281.41%
总资产收益率:-41.82%
市净率:-0.20
市盈率(LYR):-0.48

数据加载中...

2023/12/29

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/12/22

招股说明书

Form S-1 - General form for registration of securities under the Securities Act of 1933
2023/12/22

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/12/14

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/12/12

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/12/08

重要事件披露

Form 8-K - Current report
2023/12/02

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/11/29

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/11/28

重要事件披露

Form 8-K - Current report
2023/11/24

重要事件披露

Form 8-K - Current report
2023/11/18

SEC问询函

Form CORRESP - Correspondence
2023/11/16

SEC问询函

Form CORRESP - Correspondence
2023/11/15

重要事件披露

Form 8-K - Current report
2023/11/15

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2023/11/15

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/11/10

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/10

重要事件披露

Form 8-K - Current report
2023/10/27

SEC问询函

Form CORRESP - Correspondence
2023/10/24

重要事件披露

Form 8-K - Current report
2023/10/10

重要事件披露

Form 8-K - Current report